$MASI
MASIMO CORP Stock $masi

$masi Overview Financials Valuation SEC Filings Company Website

2017 Q3 Form 10-Q Financial Statement

#000093755617000214 Filed on October 31, 2017

Income Statement

Concept	2017 Q3	2016 Q4
Revenue	$193.4M	$183.2M
YoY Change	12.0%	20.07%
Cost Of Revenue	$69.30M	$57.50M
YoY Change	20.51%	14.21%
Gross Profit	$124.1M	$124.3M
YoY Change	7.76%	21.61%
Gross Profit Margin	64.16%	67.86%
Selling, General & Admin	$65.70M	$57.85M
YoY Change	2.84%	-2.96%
% of Gross Profit	52.96%	46.53%
Research & Development	$15.30M	$15.67M
YoY Change	3.25%	8.2%
% of Gross Profit	12.33%	12.61%
Depreciation & Amortization	$3.800M	$4.300M
YoY Change	-5.0%	10.26%
% of Gross Profit	3.06%	3.46%
Operating Expenses	$81.00M	$73.52M
YoY Change	2.92%	-0.77%
Operating Profit	$43.06M	$310.4M
YoY Change	18.21%	1003.06%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$287.0K	-$546.0K
YoY Change	-39.07%	-48.0%
Pretax Income	$43.35M	$36.06M
YoY Change	17.47%	33.1%
Income Tax	$7.495M	$8.285M
% Of Pretax Income	17.29%	22.98%
Net Earnings	$35.85M	$215.3M
YoY Change	19.42%	1014.06%
Net Earnings / Revenue	18.54%	117.52%
Basic Earnings Per Share	$0.69	$4.31
Diluted Earnings Per Share	$0.64	$3.97
COMMON SHARES
Basic Shares Outstanding	52.08M shares	49.48M shares
Diluted Shares Outstanding	56.16M shares	53.57M shares

Balance Sheet

Concept	2017 Q3	2016 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$331.4M	$126.0M
YoY Change	185.44%	21.62%
Cash & Equivalents	$289.9M	$306.0M
Short-Term Investments
Other Short-Term Assets	$46.84M	$26.07M
YoY Change	103.71%	-29.95%
Inventory	$99.08M	$72.54M
Prepaid Expenses	$15.11M	$13.05M
Receivables	$110.6M	$101.7M
Other Receivables	$8.300M	$7.800M
Total Short-Term Assets	$546.5M	$507.2M
YoY Change	84.64%	70.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$164.6M	$136.0M
YoY Change	23.71%	5.78%
Goodwill	$20.68M	$19.78M
YoY Change	1.43%	-3.29%
Intangibles	$27.49M	$29.38M
YoY Change	-2.74%	5.35%
Long-Term Investments		$200.0K
YoY Change
Other Assets	$11.35M	$9.223M
YoY Change	-7.36%	-18.51%
Total Long-Term Assets	$359.6M	$313.3M
YoY Change	17.24%	11.8%
TOTAL ASSETS
Total Short-Term Assets	$546.5M	$507.2M
Total Long-Term Assets	$359.6M	$313.3M
Total Assets	$906.1M	$820.5M
YoY Change	50.34%	42.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$40.25M	$34.34M
YoY Change	31.07%	19.49%
Accrued Expenses	$40.19M	$28.27M
YoY Change	50.07%	17.31%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due		$100.0K
YoY Change		0.0%
Total Short-Term Liabilities	$172.5M	$220.4M
YoY Change	43.19%	97.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$152.5M
YoY Change	-100.0%	-19.78%
Other Long-Term Liabilities	$292.0K	$14.59M
YoY Change	873.33%	98.68%
Total Long-Term Liabilities	$292.0K	$14.59M
YoY Change	873.33%	98.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$172.5M	$220.4M
Total Long-Term Liabilities	$292.0K	$14.59M
Total Liabilities	$188.8M	$260.3M
YoY Change	-38.61%	-15.91%
SHAREHOLDERS EQUITY
Retained Earnings	$720.5M	$589.2M
YoY Change	108.13%	122.8%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)	$449.5M	$404.3M
YoY Change	11.2%	27.91%
Treasury Stock Shares	14.79K shares	15.06M shares
Shareholders Equity	$717.3M	$560.2M
YoY Change
Total Liabilities & Shareholders Equity	$906.1M	$820.5M
YoY Change	50.34%	42.01%

Cashflow Statement

Concept	2017 Q3	2016 Q4
OPERATING ACTIVITIES
Net Income	$35.85M	$215.3M
YoY Change	19.42%	1014.06%
Depreciation, Depletion And Amortization	$3.800M	$4.300M
YoY Change	-5.0%	10.26%
Cash From Operating Activities	-$29.20M	$31.30M
YoY Change	-177.04%	15.5%
INVESTING ACTIVITIES
Capital Expenditures	-$4.900M	-$5.600M
YoY Change	-18.33%	-66.47%
Acquisitions
YoY Change
Other Investing Activities	-$1.100M	-$200.0K
YoY Change
Cash From Investing Activities	-$4.900M	-$5.800M
YoY Change	-16.95%	-65.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	20.90M	-15.40M
YoY Change	-138.21%	-41.22%
NET CHANGE
Cash From Operating Activities	-29.20M	31.30M
Cash From Investing Activities	-4.900M	-5.800M
Cash From Financing Activities	20.90M	-15.40M
Net Change In Cash	-13.20M	10.10M
YoY Change	-41.85%	-163.92%
FREE CASH FLOW
Cash From Operating Activities	-$29.20M	$31.30M
Capital Expenditures	-$4.900M	-$5.600M
Free Cash Flow	-$24.30M	$36.90M
YoY Change	-155.35%	-15.75%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	masi	Proceedsfromstockoptionsexercisedunsettledatperiodend Proceedsfromstockoptionsexercisedunsettledatperiodend	113000	USD
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-30
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Period End Date DocumentPeriodEndDate	2017-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0000937556
CY2017Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	51671144	shares
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	MASIMO CORP
	dei	Trading Symbol TradingSymbol	MASI
CY2016Q4	masi	Accrued Donations Current AccruedDonationsCurrent	503000	USD
CY2017Q3	masi	Accrued Donations Current AccruedDonationsCurrent	634000	USD
CY2016Q4	masi	Accrued Treasury Stock.Acquired AccruedTreasuryStock.Acquired	0	USD
CY2017Q3	masi	Accrued Treasury Stock.Acquired AccruedTreasuryStock.Acquired	2653000	USD
CY2016Q4	masi	Accruedcustomerrebatesfeesandreimbursement Accruedcustomerrebatesfeesandreimbursement	3893000	USD
CY2017Q3	masi	Accruedcustomerrebatesfeesandreimbursement Accruedcustomerrebatesfeesandreimbursement	4101000	USD
CY2016Q4	masi	Concentration Risk Longlived Asset Geographic Area Percentage ConcentrationRiskLonglivedAssetGeographicAreaPercentage	1.000
CY2017Q3	masi	Concentration Risk Longlived Asset Geographic Area Percentage ConcentrationRiskLonglivedAssetGeographicAreaPercentage	1.000
	masi	Deconsolidation Variable Interest Entity Reductionof Cash DeconsolidationVariableInterestEntityReductionofCash	-763000	USD
	masi	Deconsolidation Variable Interest Entity Reductionof Cash DeconsolidationVariableInterestEntityReductionofCash	0	USD
CY2017Q3	masi	Estimateof Annual Preventable Hospital Deaths Preventedby2020 EstimateofAnnualPreventableHospitalDeathsPreventedby2020	200000	death
CY2007Q1	masi	Numberof Companieswith Rightsto Intellectual Property NumberofCompanieswithRightstoIntellectualProperty	2	company
CY2014Q1	masi	Numberof Participantsinthe Surfactant Positive Pressureand Oxygenation Randomized Trial NumberofParticipantsintheSurfactantPositivePressureandOxygenationRandomizedTrial	2	participant
	masi	Numberof Sourcesof Product Revenue NumberofSourcesofProductRevenue	4	segment
CY2016Q4	masi	Percentage Of Revenue One Customer PercentageOfRevenueOneCustomer	0.140
	masi	Percentage Of Revenue One Customer PercentageOfRevenueOneCustomer	0.150
CY2017Q3	masi	Percentage Of Revenue One Customer PercentageOfRevenueOneCustomer	0.123
	masi	Percentage Of Revenue One Customer PercentageOfRevenueOneCustomer	0.132
CY2016Q4	masi	Percentage Of Revenue Two Customer PercentageOfRevenueTwoCustomer	0.132
	masi	Percentage Of Revenue Two Customer PercentageOfRevenueTwoCustomer	0.124
CY2017Q3	masi	Percentage Of Revenue Two Customer PercentageOfRevenueTwoCustomer	0.109
	masi	Percentage Of Revenue Two Customer PercentageOfRevenueTwoCustomer	0.114
	masi	Proceedsfrom Treasury Stock Acquired Unsettledat Period End ProceedsfromTreasuryStockAcquiredUnsettledatPeriodEnd	0	USD
	masi	Proceedsfrom Treasury Stock Acquired Unsettledat Period End ProceedsfromTreasuryStockAcquiredUnsettledatPeriodEnd	2653000	USD
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.03
	us-gaap	Depreciation Depreciation	9500000	USD
CY2017Q3	masi	Royalty Receivable RoyaltyReceivable	7800000	USD
	masi	Proceedsfromstockoptionsexercisedunsettledatperiodend Proceedsfromstockoptionsexercisedunsettledatperiodend	476000	USD
	masi	Property Plantand Equipment Occupied Square Feet PropertyPlantandEquipmentOccupiedSquareFeet	16830	sqft
CY2016Q4	masi	Royalty Royalty	7335000	USD
	masi	Royalty Royalty	23241000	USD
CY2016Q4	masi	Royalty Receivable RoyaltyReceivable	7500000	USD
	masi	Royalty Revenue Numberof Days Royalty Revenueis Adjusted Subsequentto Quarter End RoyaltyRevenueNumberofDaysRoyaltyRevenueisAdjustedSubsequenttoQuarterEnd	P60D
CY2017Q3	masi	Royaltyrevenueandother Royaltyrevenueandother	12421000	USD
	masi	Royaltyrevenueandother Royaltyrevenueandother	30757000	USD
CY2017Q3	masi	Severance Plan Participation Agreements SeverancePlanParticipationAgreements	6	Agreement
	masi	Supplemental Unemployment Benefits Severance Benefits Required Noticeof Resignation SupplementalUnemploymentBenefitsSeveranceBenefitsRequiredNoticeofResignation	P6M
CY2016Q4	masi	Unrecognized Tax Benefits Liabilities Noncurrent UnrecognizedTaxBenefitsLiabilitiesNoncurrent	13442000	USD
CY2017Q3	masi	Unrecognized Tax Benefits Liabilities Noncurrent UnrecognizedTaxBenefitsLiabilitiesNoncurrent	14078000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	34334000	USD
CY2017Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	40251000	USD
CY2016Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	10673000	USD
CY2017Q3	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	14365000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	101667000	USD
CY2017Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	110614000	USD
CY2016Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	77000	USD
CY2017Q3	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	23000	USD
CY2016Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	5135000	USD
CY2017Q3	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	4990000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	104654000	USD
CY2017Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	40189000	USD
CY2016Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	1362000	USD
CY2017Q3	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	1263000	USD
CY2016Q4	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	700000	USD
CY2017Q3	us-gaap	Accrued Rent Current And Noncurrent AccruedRentCurrentAndNoncurrent	1500000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	68233000	USD
CY2017Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	79119000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-7027000	USD
CY2017Q3	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	-2757000	USD
	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	382263000	USD
CY2017Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	449050000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1698	USD
CY2017Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1413	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2800000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3700000	USD
CY2016Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	100000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1400000	shares
CY2017Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	600000	shares
CY2016Q4	us-gaap	Assets Assets	820525000	USD
CY2017Q3	us-gaap	Assets Assets	906071000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	507227000	USD
CY2017Q3	us-gaap	Assets Current AssetsCurrent	546480000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1232000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3349000	USD
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	0	USD
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	0	USD
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	0	USD
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	0	USD
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	0	USD
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	0	USD
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Interest Included In Payments CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments	100000	USD
CY2017Q3	us-gaap	Capital Leases Future Minimum Payments Remainder Of Fiscal Year CapitalLeasesFutureMinimumPaymentsRemainderOfFiscalYear	0	USD
CY2017Q3	us-gaap	Cash Cash	277600000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	132317000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	125988000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	305970000	USD
CY2017Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	289944000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-6329000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-16026000	USD
CY2017Q3	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	3900000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	14100000	shares
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	50188	shares
CY2017Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	51671	shares
CY2016Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	50000	USD
CY2017Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	52000	USD
CY2016Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	27303000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	85093000	USD
CY2017Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	40640000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	135518000	USD
CY2016Q4	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
CY2017Q3	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
	us-gaap	Concentration Risk Percentage1 ConcentrationRiskPercentage1	1.000
CY2017Q3	us-gaap	Contractual Obligation ContractualObligation	26415000	USD
CY2017Q3	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	7284000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	2615000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	3165000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	6347000	USD
CY2017Q3	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	5363000	USD
CY2017Q3	us-gaap	Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear	1641000	USD
CY2016Q4	us-gaap	Cost Of Goods Sold CostOfGoodsSold	57499000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	171954000	USD
CY2017Q3	us-gaap	Cost Of Goods Sold CostOfGoodsSold	65027000	USD
	us-gaap	Cost Of Goods Sold CostOfGoodsSold	191692000	USD
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	273000	USD
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
CY2016Q2	us-gaap	Deconsolidation Revaluation Of Retained Investment Gain Or Loss Amount DeconsolidationRevaluationOfRetainedInvestmentGainOrLossAmount	0.3	USD
	us-gaap	Interest Paid Net InterestPaidNet	432000	USD
CY2016Q4	us-gaap	Deferred Costs DeferredCosts	79948000	USD
CY2017Q3	us-gaap	Deferred Costs DeferredCosts	96464000	USD
CY2016Q4	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	14587000	USD
CY2017Q3	us-gaap	Deferred Credits And Other Liabilities DeferredCreditsAndOtherLiabilities	16059000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5002000	USD
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	558000	USD
CY2017Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1350000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	38198000	USD
CY2017Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	57369000	USD
CY2016Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	25336000	USD
CY2017Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	261000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	38975000	USD
CY2017Q3	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	39029000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	340000	USD
CY2017Q3	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	339000	USD
	us-gaap	Depreciation Depreciation	10800000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12355000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14384000	USD
CY2016Q4	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	0	USD
CY2017Q3	us-gaap	Due From Affiliate Current DueFromAffiliateCurrent	8571000	USD
CY2016Q4	us-gaap	Due From Employees Current DueFromEmployeesCurrent	305000	USD
CY2017Q3	us-gaap	Due From Employees Current DueFromEmployeesCurrent	338000	USD
CY2016Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	525000	USD
CY2017Q3	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1028000	USD
CY2016Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.56
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.73
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.75
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.55
CY2016Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.52
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.62
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.70
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.35
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-382000	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	3112000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	43180000	USD
CY2017Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	34660000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	21313000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	24252000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	7975000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	5343000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2330000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3362000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3710000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4769000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50689000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	51741000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	29376000	USD
CY2017Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	27489000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-478000	USD
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-420000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	19780000	USD
CY2017Q3	us-gaap	Goodwill Goodwill	20676000	USD
CY2016Q4	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2017Q3	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	USD
CY2016Q4	us-gaap	Gross Profit GrossProfit	110122000	USD
	us-gaap	Gross Profit GrossProfit	339470000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	128665000	USD
	us-gaap	Gross Profit GrossProfit	381235000	USD
CY2016Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	36058000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	110793000	USD
CY2017Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	48262000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	139356000	USD
CY2016Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8285000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	25420000	USD
CY2017Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9027000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8108000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	25753000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	86759000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9386000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3748000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13398000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	17277000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-384000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-66918000	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	11278000	USD
	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	16166000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	10934000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-5905000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-810000	USD
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-9094000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5092000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	25998000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	12911000	USD
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	11099000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	2117000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	964000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1072000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1456000	USD
CY2016Q4	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4088000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3451000	shares
CY2017Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	42023000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7701000	USD
CY2017Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4084000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4498000	shares
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	29376000	USD
CY2017Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	27489000	USD
	us-gaap	Interest Paid Net InterestPaidNet	2603000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	32194000	USD
CY2017Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	48838000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	72542000	USD
CY2017Q3	us-gaap	Inventory Net InventoryNet	99078000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	32647000	USD
CY2017Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8217000	USD
CY2016Q4	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1600000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	4500000	USD
CY2017Q3	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	1700000	USD
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	5000000	USD
CY2017Q3	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	300000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	260289000	USD
CY2017Q3	us-gaap	Liabilities Liabilities	188789000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	820525000	USD
CY2017Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	906071000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	220366000	USD
CY2017Q3	us-gaap	Liabilities Current LiabilitiesCurrent	172469000	USD
CY2017Q3	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	0	USD
CY2017Q3	us-gaap	Loss Contingency Estimate Of Possible Loss LossContingencyEstimateOfPossibleLoss	8600000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-75348000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	13030000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-18629000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-41195000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	88030000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9027000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	27773000	USD
	us-gaap	Net Income Loss NetIncomeLoss	85373000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	39235000	USD
	us-gaap	Net Income Loss NetIncomeLoss	131248000	USD
CY2016Q4	us-gaap	Noncurrent Assets NoncurrentAssets	225167000	USD
CY2017Q3	us-gaap	Noncurrent Assets NoncurrentAssets	272397000	USD
CY2016Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-546000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	423000	USD
CY2017Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	287000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1319000	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	73518000	USD
	us-gaap	Operating Expenses OperatingExpenses	229100000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	80690000	USD
	us-gaap	Operating Expenses OperatingExpenses	243198000	USD
CY2016Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	36604000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	110370000	USD
CY2017Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	47975000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	138037000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	26415000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	2615000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	3165000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	5363000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	6347000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	7284000	USD
CY2017Q3	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	1641000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5337000	USD
CY2017Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4756000	USD
CY2016Q4	us-gaap	Other Assets Current OtherAssetsCurrent	27048000	USD
CY2017Q3	us-gaap	Other Assets Current OtherAssetsCurrent	46844000	USD
CY2016Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	5134000	USD
CY2017Q3	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	5377000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9223000	USD
CY2017Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11354000	USD
CY2017Q3	us-gaap	Other Commitment OtherCommitment	300000	USD
CY2016Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-470000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-280000	USD
CY2017Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1405000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	4270000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	247000	USD
CY2017Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	292000	USD
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	7700000	USD
	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	35100000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	68218000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	42608000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	621000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	3969000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2220000	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	200000	USD
	us-gaap	Payments To Acquire Longterm Investments PaymentsToAcquireLongtermInvestments	1145000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13697000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37830000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	55709000	USD
CY2016Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1222000	USD
CY2016Q4	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2017Q3	us-gaap	Preferred Stock Value Outstanding PreferredStockValueOutstanding	0	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13051000	USD
CY2017Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	15113000	USD
CY2016Q4	us-gaap	Prepaid Taxes PrepaidTaxes	981000	USD
CY2017Q3	us-gaap	Prepaid Taxes PrepaidTaxes	9622000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	45000000	USD
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	26063000	USD
CY2016Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	910000	USD
CY2016Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1292000	USD
CY2017Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	1020000	USD
CY2016Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	910000	USD
CY2017Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	1220000	USD
	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	722000	USD
	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	712000	USD
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	99000	USD
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-116000	USD
	us-gaap	Product Warranty Expense ProductWarrantyExpense	751000	USD
	us-gaap	Product Warranty Expense ProductWarrantyExpense	486000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	27773000	USD
	us-gaap	Profit Loss ProfitLoss	85373000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	39235000	USD
	us-gaap	Profit Loss ProfitLoss	131248000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	204229000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	243698000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	135996000	USD
CY2017Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	164579000	USD
CY2017Q3	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	81600000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	77500000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	72000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	71000	USD
CY2016Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15673000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	44856000	USD
CY2017Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	15300000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45859000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	589226000	USD
CY2017Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	720474000	USD
CY2016Q4	us-gaap	Revenues Revenues	167621000	USD
	us-gaap	Revenues Revenues	511424000	USD
CY2017Q3	us-gaap	Revenues Revenues	193692000	USD
	us-gaap	Revenues Revenues	572927000	USD
	us-gaap	Royalty Revenue RoyaltyRevenue	25700000	USD
CY2016Q4	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	160286000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	488183000	USD
CY2017Q3	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	181271000	USD
	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	542170000	USD
CY2016Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	57845000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	184244000	USD
CY2017Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	65390000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	197339000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	9693000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	11192000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.356
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.374
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.319
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.357
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.323
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.320
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.303
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.303
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.018
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.019
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.013
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.019
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.015
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.013
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.010
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.010
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	4000000	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	3991000	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	26.26
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	17400000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	220000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	847000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	17.99
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	13.42
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	27.70
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	27.74
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	365900000	USD
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8521000	shares
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	7139000	shares
CY2016Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	28.56
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	35.48
CY2017Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	240700000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	27.66
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	36.49
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	86.80
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	9700000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	11200000	USD
CY2016Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M12D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y8M12D
CY2017Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y6M
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2009000	shares
CY2015Q3	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	5000000.0	shares
CY2017Q3	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	2400000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	560236000	USD
CY2017Q3	us-gaap	Stockholders Equity StockholdersEquity	717282000	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	76316000	USD
CY2017Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	5179000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	14255	shares
CY2017Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	14788	shares
CY2016Q4	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1496000	shares
CY2017Q3	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	84.86
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	84.86
CY2017Q3	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	533000	shares
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	533000	shares
CY2016Q4	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	0
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	42.39
CY2016Q4	us-gaap	Treasury Stock Value TreasuryStockValue	404276000	USD
CY2017Q3	us-gaap	Treasury Stock Value TreasuryStockValue	449537000	USD
CY2016Q4	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	0	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	63403000	USD
CY2017Q3	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	45261000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	45261000	USD
CY2017Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	15200000	USD
CY2017Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	13500000	USD
CY2016Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	53565000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	52837000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56163000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	55967000	shares
CY2016Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49477000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49386000	shares
CY2017Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	52079000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	51469000	shares
	us-gaap	Fiscal Period FiscalPeriod	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Fiscal Periods</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company follows a conventional 52/53 week fiscal year. Under a conventional 52/53 week fiscal year, a 52 week fiscal year includes four quarters of 13 fiscal weeks while a 53 week fiscal year includes three 13 fiscal week quarters and one 14 fiscal week quarter. The Company’s last 53 week fiscal year was fiscal year 2014. Fiscal year </font><font style="font-family:inherit;font-size:10pt;">2017</font><font style="font-family:inherit;font-size:10pt;"> is a 52 week fiscal year. All references to years in these notes to condensed consolidated financial statements are fiscal years unless otherwise noted.</font></div></div>
	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> Description of the Company</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Masimo Corporation (the Company) is a global medical technology company that develops, manufactures and markets a variety of noninvasive patient monitoring technologies. The Company’s mission is to improve patient outcomes and reduce cost of care by taking noninvasive monitoring to new sites and applications</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">. The Company’s patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The Company primarily sells its products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long term care facilities and consumers through its direct sales force, distributors and original equipment manufacturer (OEM) partners.</font></div><div style="line-height:120%;padding-top:12px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company invented Masimo Signal Extraction Technology</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt"> </sup></font><font style="font-family:inherit;font-size:10pt;">(SET</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">), which provides the capabilities of </font><font style="font-family:inherit;font-size:10pt;">Measure-through Motion and Low Perfusion</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">™</sup></font><font style="font-family:inherit;font-size:10pt;"> pulse oximetry to address the primary limitations of conventional pulse oximetry. Over the years, the Company’s product offerings have expanded significantly to also include noninvasive optical blood constituent monitoring, optical organ oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring and optical gas monitoring. The Company also developed the Root</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> patient monitoring and connectivity platform and the Masimo Patient SafetyNet</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">1</sup></font><font style="font-family:inherit;font-size:10pt;"> remote patient surveillance monitoring system. These solutions and related products are based upon Masimo SET</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;">, rainbow</font><font style="font-family:inherit;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">®</sup></font><font style="font-family:inherit;font-size:10pt;"> and other proprietary algorithms. These software-based technologies are incorporated into a variety of product platforms depending on customers’ specifications. In addition, these technologies are supported by a substantial intellectual property portfolio that the Company has built through internal development, acquisitions and license agreements.</font></div></div>
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:17px;text-align:left;padding-left:18px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications</font><font style="font-family:inherit;font-size:12pt;"> </font></div><div style="line-height:120%;padding-top:6px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain amounts in the accompanying condensed consolidated financial statements for prior periods have been reclassified to conform to the current period presentation. </font></div></div>
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:8pt;"></font><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;padding-top:17px;text-indent:16px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:6px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company prepares its financial statements in conformity with GAAP, which requires the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates include the determination of accounts receivable allowances, inventory reserves, warranty reserves, rebate accruals, valuation of the Company’s stock options, goodwill valuation, deferred taxes and any associated valuation allowances, distributor channel inventory, royalty revenues, deferred revenue, uncertain income tax positions, litigation costs and related accruals. Actual results could differ from such estimates.</font></div><div style="line-height:120%;padding-top:17px;text-align:left;padding-left:18px;font-size:12pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;"></font></div></div>

Files In Submission

Name	View Source	Status
0000937556-17-000214-index-headers.html	Edgar Link	pending
0000937556-17-000214-index.html	Edgar Link	pending
0000937556-17-000214.txt	Edgar Link	pending
0000937556-17-000214-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
masi-20170930.xml	Edgar Link	completed
masi-20170930.xsd	Edgar Link	pending
masi-20170930x10q.htm	Edgar Link	pending
masi-20170930x10qex121.htm	Edgar Link	pending
masi-20170930x10qex311.htm	Edgar Link	pending
masi-20170930x10qex312.htm	Edgar Link	pending
masi-20170930x10qex321.htm	Edgar Link	pending
masi-20170930_cal.xml	Edgar Link	unprocessable
masi-20170930_def.xml	Edgar Link	unprocessable
masi-20170930_lab.xml	Edgar Link	unprocessable
masi-20170930_pre.xml	Edgar Link	unprocessable
masimologoq32016-01a03.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MASI
MASIMO CORP Stock $masi

2017 Q3 Form 10-Q Financial Statement

#000093755617000214 Filed on October 31, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MASI MASIMO CORP Stock $masi

2017 Q3 Form 10-Q Financial Statement

#000093755617000214 Filed on October 31, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MASI
MASIMO CORP Stock $masi